HRMY
Harmony Biosciences Holdings Inc

17,046
Mkt Cap
$1.6B
Volume
1.03M
52W High
$40.87
52W Low
$25.52
PE Ratio
10.23
HRMY Fundamentals
Price
$27.72
Prev Close
$27.81
Open
$27.90
50D MA
$33.21
Beta
0.85
Avg. Volume
1.3M
EPS (Annual)
$2.71
P/B
1.84
Rev/Employee
$2.96M
$1,650.46
Loading...
Loading...
News
all
press releases
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?
Investors need to pay close attention to Harmony Biosciences stock based on the movements in the options market lately.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·7d ago
News Placeholder
Zuckerman Investment Group LLC Invests $3.40 Million in Harmony Biosciences Holdings, Inc. $HRMY
Zuckerman Investment Group LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the third quarter, according to its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd cut its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 92.7% during the third quarter, according to its most recent disclosure with...
MarketBeat·7d ago
News Placeholder
Harmony Biosciences Holdings, Inc. $HRMY Shares Acquired by American Century Companies Inc.
American Century Companies Inc. lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 11.2% in the 3rd quarter, according to the company in its most recent...
MarketBeat·15d ago
News Placeholder
Harmony Biosciences to Participate in Upcoming Investor Conferences
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will attend the following upcoming investor conferences. Leerink Partners Global Healthcare...
Business Wire·17d ago
News Placeholder
HC Wainwright Issues Pessimistic Forecast for HRMY Earnings
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Analysts at HC Wainwright cut their FY2026 earnings per share (EPS) estimates for Harmony Biosciences in a note issued to investors on...
MarketBeat·20d ago
News Placeholder
Harmony Biosciences (NASDAQ:HRMY) Downgraded by Wall Street Zen to Hold
Wall Street Zen lowered shares of Harmony Biosciences from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·21d ago
News Placeholder
HC Wainwright Issues Negative Estimate for HRMY Earnings
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Equities researchers at HC Wainwright lowered their Q1 2026 earnings per share (EPS) estimates for shares of Harmony Biosciences in a...
MarketBeat·22d ago
News Placeholder
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Harmony Biosciences from a "strong-buy" rating to a "hold" rating in a research report on Wednesday...
MarketBeat·22d ago
<
1
2
...
>

Latest HRMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.